There are several strengths of our study including an evaluation of primary human tissue samples and tumors, use of multiple established CRC cell lines, and the use f rescue experiments to support the TCF7L1/LGR5 pathway as a critical regulator of CRC stemness. The gene discussed is LGR5; the disease is colorectal carcinoma.